Mirza Shaper, Qu Hui-Qi, Li Quan, Martinez Perla J, Rentfro Anne R, McCormick Joseph B, Fisher-Hoch Susan P
University of Texas Health Science Center atHouston, School of Public Health, Brownsville Campus, USA.
Clin Invest Med. 2011 Oct 1;34(5):E290. doi: 10.25011/cim.v34i5.15672.
Adiponectin and leptin play critical roles in the development of Metabolic Syndrome (MetS). This study was designed to assess the feasibility of using circulating levels of adiponectin and leptin for the early diagnosis of MetS.
A cross-sectional study was performed using data from 367 participants randomly selected from a well-characterized cohort of Mexican-Americans living at the US-Mexico border.
Significant differences in circulating levels of adiponectin and leptin were observed between males and females. Adiponectin/leptin correlated significantly with MetS in this population. A receiver-operator characteristic (ROC) analysis demonstrated that adiponectin/leptin showed a high sensitivity (70.9% for males, 78.9% for females) and specificity (90.2% for males and 69.8% for females) for the diagnosis of MetS, independent of BMI measurements.
These data support the central role of adiponectin and leptin in MetS, and demonstrated that adiponectin/leptin can be used as a highly sensitive and specific biomarker for MetS.
脂联素和瘦素在代谢综合征(MetS)的发生发展中起关键作用。本研究旨在评估利用循环中脂联素和瘦素水平进行MetS早期诊断的可行性。
采用横断面研究,数据来自从居住在美国 - 墨西哥边境的墨西哥裔美国人特征明确的队列中随机选取的367名参与者。
观察到男性和女性循环中脂联素和瘦素水平存在显著差异。在该人群中,脂联素/瘦素与MetS显著相关。受试者工作特征(ROC)分析表明,脂联素/瘦素对MetS诊断具有高敏感性(男性为70.9%,女性为78.9%)和特异性(男性为90.2%,女性为69.8%),且独立于体重指数测量。
这些数据支持脂联素和瘦素在MetS中的核心作用,并表明脂联素/瘦素可作为MetS的高敏感性和特异性生物标志物。